Skip to main content
Quest Diagnostics

Prenatal Theoretical Diagnostic Yield of a Rapid, Targeted Genetic Panel Designed for Critically Ill Pediatric Patients

NSGC 2020: National Society of Genetic Counselors 39th Virtual Annual Conference
Virtual [in-person conference canceled], November 17 - 22, 2020

Prenatal Theoretical Diagnostic Yield of a Rapid, Targeted Genetic Panel Designed for Critically Ill Pediatric Patients

Authors: Stachiw-Hietpas DL, Kucera CR, Partack EJ, Witherington SE, Hahn SE, Tanpaiboon P, Mullen TE

Specialties: Genetics, Pediatrics, Women's health, OB/GYN

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.